EYENOVIA INC. - COMMO

Eyenovia Announces $15 Million Credit Facility with Avenue Venture Debt Fund

29 Nov 2022 08:00:00 By Nasdaq GlobeNewswire

Eyenovia to Present at Upcoming BTIG Ophthalmology Day

23 Nov 2022 16:05:00 By Nasdaq GlobeNewswire

Eyenovia Reports Third Quarter 2022 Financial Results and Provides Business Update

10 Nov 2022 16:05:04 By Nasdaq GlobeNewswire

Eyenovia to Report Third Quarter 2022 Results on Thursday, November 10

03 Nov 2022 08:00:02 By Nasdaq GlobeNewswire

Eyenovia to Present at the American Academy of Optometry’s Annual Meeting

21 Oct 2022 08:00:00 By Nasdaq GlobeNewswire

Eyenovia Announces Positive Results from VISION-2 Phase 3 Study of MicroLine as a Potential On-Demand Treatment for Presbyopia

20 Oct 2022 08:00:02 By Nasdaq GlobeNewswire

Eyenovia Announces Planned Retirement of Lead Independent Director Ken Lee, Jr.

30 Sep 2022 08:00:00 By Nasdaq GlobeNewswire

Eyenovia to Present at Upcoming Healthcare Conferences

07 Sep 2022 08:00:03 By Nasdaq GlobeNewswire

Eyenovia to Participate in Multiple Medical Meetings in September

06 Sep 2022 08:00:03 By Nasdaq GlobeNewswire

Eyenovia Reports Second Quarter 2022 Financial Results

10 Aug 2022 16:05:01 By Nasdaq GlobeNewswire

Eyenovia to Report Second Quarter 2022 Results on Wednesday, August 10

04 Aug 2022 08:00:02 By Nasdaq GlobeNewswire

Eyenovia Announces Appointment of Ophthalmic Industry Veteran Michael Rowe as Chief Executive Officer and Board Member

27 Jul 2022 08:00:03 By Nasdaq GlobeNewswire

Eyenovia Provides Manufacturing Update and Announces Appointment of Bren Kern as SVP of Manufacturing and Operations

18 Jul 2022 08:00:01 By Nasdaq GlobeNewswire

Eyenovia Announces Appointments of Dr. Ellen Strahlman and Dr. Ram Palanki as New and Independent Members of its Board of Directors

07 Jul 2022 08:00:01 By Nasdaq GlobeNewswire

Eyenovia Strategic Partner Arctic Vision Enrolls First Patient in Phase III Clinical Trial of ARVN003 (MicroLine) for Presbyopia in China

06 Jul 2022 08:00:02 By Nasdaq GlobeNewswire

UPDATE: Eyenovia Announces Virtual 2022 Annual Meeting of Stockholders

09 Jun 2022 10:09:12 By Nasdaq GlobeNewswire

Eyenovia Announces Virtual 2022 Annual Meeting of Stockholders

09 Jun 2022 08:00:01 By Nasdaq GlobeNewswire

Eyenovia Announces Planned Chief Executive Officer Transition

07 Jun 2022 08:00:01 By Nasdaq GlobeNewswire

Eyenovia Reports First Quarter 2022 Financial Results

12 May 2022 16:05:01 By Nasdaq GlobeNewswire

Eyenovia to Report First Quarter 2022 Results on Thursday, May 12

05 May 2022 08:00:03 By Nasdaq GlobeNewswire